Vera Therapeutics Inc - Class A (VERA) Company Profile & Statistics

Vera Therapeutics Inc - Class A
VERA
(Nasdaq - US)
Open
43.88
-2.38 (-5.14%)
in:usd•As of: Nov 18, 2024 13:25 UTC -5
Open
47.25
High
47.25
Low
43.47

About Vera Therapeutics Inc - Class A

CEO

Marshall Fordyce

Headquarters

8000 marina boulevard, suite 120

brisbane, ca 94005, united states

Auditor

KPMG LLP

Employees

Share Holders

Website

www.veratx.com

Industry

biotechnology

Sector

health technology

Company Overview

Vera Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Vera Therapeutics Inc. is based in SOUTH SAN FRANCISCO, Calif.

Vera Therapeutics Inc - Class A Statistics

Valuation Measures

Market Capitalization ²	2.93B
Enterprise Value	2.95B
Enterprise Value/EBITDA (ttm)	-19.33
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	8.81
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-50.13%
Return on Invested Capital (ttm)	-46.61%
Return on Assets (ttm)	-39.50%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-152.71M
Net Income Avi to Common (ttm)	-134.38M
Diluted EPS (ttm)	-2.61

Share Statistics

Beta (5Y Monthly)	1.03
52-Week Change	225.04%
S&P500 52-Week Change	29.71%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	63.32M
Dividend Yield	0.00%
Float ⁴	49.58M
% Held by Insiders	21.70%
% Held by Institutions	99.21%

Balance Sheet

Total Cash (mrq)	353.31M
Total Cash Per Share (mrq)	5.58
Total Debt (mrq)	50.47M
Total Debt/Equity (mrq)	17.46%
Current Ratio (mrq)	13.76%
Quick Ratio (mrq)	13.76%
Book Value Per Share (mrq)	5.25

Cash Flow

Operating Cash Flow Per Share (ytd)	-1.74
Free Cash Flow (ytd)	-95.82M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Vera Therapeutics Inc - Class A

Trade With A Regulated Broker